Connection

Anand Mehta to Humans

Back to Details
This is a "connection" page, showing publications Anand Mehta has written about Humans.
Anand Mehta
Connection Strength
0.629
Humans
  1. Beyond glyco-proteomics-Understanding the role of genetics in cancer biomarkers. Adv Cancer Res. 2023; 157:57-81.
    View in: PubMed
    Score: 0.032
  2. GlycoFibroTyper: A Novel Method for the Glycan Analysis of IgG and the Development of a Biomarker Signature of Liver Fibrosis. Front Immunol. 2022; 13:797460.
    View in: PubMed
    Score: 0.031
  3. N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes. Mol Cancer Res. 2021 11; 19(11):1868-1877.
    View in: PubMed
    Score: 0.030
  4. New Enzymatic Approach to Distinguish Fucosylation Isomers of N-Linked Glycans in Tissues Using MALDI Imaging Mass Spectrometry. J Proteome Res. 2020 08 07; 19(8):2989-2996.
    View in: PubMed
    Score: 0.027
  5. Antibody Panel Based N-Glycan Imaging for N-Glycoprotein Biomarker Discovery. Curr Protoc Protein Sci. 2019 12; 98(1):e99.
    View in: PubMed
    Score: 0.026
  6. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review. World J Gastroenterol. 2019 Jun 21; 25(23):2947-2960.
    View in: PubMed
    Score: 0.026
  7. A Novel Mass Spectrometry Platform for Multiplexed N-Glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-Glycan Imaging. Anal Chem. 2019 07 02; 91(13):8429-8435.
    View in: PubMed
    Score: 0.026
  8. N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging. J Proteome Res. 2018 10 05; 17(10):3454-3462.
    View in: PubMed
    Score: 0.024
  9. Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma. PLoS One. 2018; 13(8):e0203149.
    View in: PubMed
    Score: 0.024
  10. Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma. J Immunol Methods. 2018 11; 462:59-64.
    View in: PubMed
    Score: 0.024
  11. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. Curr Opin Pharmacol. 2018 08; 41:74-78.
    View in: PubMed
    Score: 0.024
  12. Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma. Proteomics Clin Appl. 2017 09; 11(9-10).
    View in: PubMed
    Score: 0.022
  13. Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):795-803.
    View in: PubMed
    Score: 0.022
  14. A ubiquitin independent degradation pathway utilized by a hepatitis B virus envelope protein to limit antigen presentation. PLoS One. 2011; 6(9):e24477.
    View in: PubMed
    Score: 0.015
  15. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1914-21.
    View in: PubMed
    Score: 0.013
  16. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res. 2009 Feb; 8(2):595-602.
    View in: PubMed
    Score: 0.012
  17. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J Virol. 2008 Feb; 82(3):1259-70.
    View in: PubMed
    Score: 0.011
  18. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res. 2006 Feb; 5(2):308-15.
    View in: PubMed
    Score: 0.010
  19. alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins. Antivir Chem Chemother. 2006; 17(5):259-67.
    View in: PubMed
    Score: 0.010
  20. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A. 2005 Jan 18; 102(3):779-84.
    View in: PubMed
    Score: 0.009
  21. Assays for glucosidase inhibitors with potential antiviral activities: secreted alkaline phosphatase as a surrogate marker. J Virol Methods. 2005 Mar; 124(1-2):167-72.
    View in: PubMed
    Score: 0.009
  22. Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer. Sci Rep. 2022 Dec 02; 12(1):20801.
    View in: PubMed
    Score: 0.008
  23. Acute lyme disease IgG N-linked glycans contrast the canonical inflammatory signature. Front Immunol. 2022; 13:949118.
    View in: PubMed
    Score: 0.008
  24. Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. Mol Cell Proteomics. 2022 05; 21(5):100225.
    View in: PubMed
    Score: 0.008
  25. Pro-inflammatory IgG1 N-glycan signature correlates with primary graft dysfunction onset in COPD patients. Transpl Immunol. 2022 04; 71:101491.
    View in: PubMed
    Score: 0.008
  26. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. J Clin Invest. 2021 08 16; 131(16).
    View in: PubMed
    Score: 0.007
  27. Applications and continued evolution of glycan imaging mass spectrometry. Mass Spectrom Rev. 2023 03; 42(2):674-705.
    View in: PubMed
    Score: 0.007
  28. Collagen fiber regulation in human pediatric aortic valve development and disease. Sci Rep. 2021 05 07; 11(1):9751.
    View in: PubMed
    Score: 0.007
  29. Spatial N-glycomics of the human aortic valve in development and pediatric endstage congenital aortic valve stenosis. J Mol Cell Cardiol. 2021 05; 154:6-20.
    View in: PubMed
    Score: 0.007
  30. Optimization of Multiple Glycosidase and Chemical Stabilization Strategies for N-Glycan Isomer Detection by Mass Spectrometry Imaging in Formalin-Fixed, Paraffin-Embedded Tissues. Methods Mol Biol. 2021; 2271:303-316.
    View in: PubMed
    Score: 0.007
  31. Array-Based N-Glycan Profiling of Cells in Culture. Methods Mol Biol. 2021; 2271:331-342.
    View in: PubMed
    Score: 0.007
  32. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues. Mol Cell Proteomics. 2021; 20:100012.
    View in: PubMed
    Score: 0.007
  33. Multiplexed imaging mass spectrometry of the extracellular matrix using serial enzyme digests from formalin-fixed paraffin-embedded tissue sections. Anal Bioanal Chem. 2021 Apr; 413(10):2709-2719.
    View in: PubMed
    Score: 0.007
  34. Rapid N-Glycan Profiling of Serum and Plasma by a Novel Slide-Based Imaging Mass Spectrometry Workflow. J Am Soc Mass Spectrom. 2020 Dec 02; 31(12):2511-2520.
    View in: PubMed
    Score: 0.007
  35. Biomarkers for the Early Detection of Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2495-2503.
    View in: PubMed
    Score: 0.007
  36. Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry. J Mass Spectrom. 2020 Apr; 55(4):e4490.
    View in: PubMed
    Score: 0.007
  37. Core-Fucosylated Tetra-Antennary N-Glycan Containing A Single N-Acetyllactosamine Branch Is Associated with Poor Survival Outcome in Breast Cancer. Int J Mol Sci. 2019 May 23; 20(10).
    View in: PubMed
    Score: 0.006
  38. Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues. Proteomics Clin Appl. 2019 01; 13(1):e1800014.
    View in: PubMed
    Score: 0.006
  39. Extracellular Matrix Imaging of Breast Tissue Pathologies by MALDI-Imaging Mass Spectrometry. Proteomics Clin Appl. 2019 01; 13(1):e1700152.
    View in: PubMed
    Score: 0.006
  40. In Situ Imaging of N-Glycans by MALDI Imaging Mass Spectrometry of Fresh or Formalin-Fixed Paraffin-Embedded Tissue. Curr Protoc Protein Sci. 2018 11; 94(1):e68.
    View in: PubMed
    Score: 0.006
  41. MALDI Imaging Mass Spectrometry of N-glycans and Tryptic Peptides from the Same Formalin-Fixed, Paraffin-Embedded Tissue Section. Methods Mol Biol. 2018; 1788:225-241.
    View in: PubMed
    Score: 0.006
  42. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Tissues. Adv Exp Med Biol. 2018; 1104:59-76.
    View in: PubMed
    Score: 0.006
  43. Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section. Anal Chem. 2016 08 02; 88(15):7745-53.
    View in: PubMed
    Score: 0.005
  44. Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry. Biomolecules. 2015 Oct 15; 5(4):2554-72.
    View in: PubMed
    Score: 0.005
  45. Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins. J Proteome Res. 2015 Jun 05; 14(6):2594-605.
    View in: PubMed
    Score: 0.005
  46. MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays. PLoS One. 2014; 9(9):e106255.
    View in: PubMed
    Score: 0.005
  47. Lectin-reactive anti-a-gal in patients with Crohn's disease: correlation with clinical phenotypes. Inflamm Bowel Dis. 2013 Dec; 19(13):2796-800.
    View in: PubMed
    Score: 0.004
  48. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Anal Chem. 2013 Oct 15; 85(20):9799-806.
    View in: PubMed
    Score: 0.004
  49. Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort. AIDS. 2013 Jan 14; 27(2):191-201.
    View in: PubMed
    Score: 0.004
  50. Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73. Cancer Biomark. 2012; 11(4):161-71.
    View in: PubMed
    Score: 0.004
  51. Overexpression of a1,6-fucosyltransferase in hepatoma enhances expression of Golgi phosphoprotein 2 in a fucosylation-independent manner. Int J Oncol. 2011 Jul; 39(1):203-8.
    View in: PubMed
    Score: 0.004
  52. Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks. Hepatology. 2010 Oct; 52(4):1242-50.
    View in: PubMed
    Score: 0.003
  53. Hepatocellular carcinoma of the liver. Cancer Biomark. 2010; 9(1-6):375-83.
    View in: PubMed
    Score: 0.003
  54. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids. J Proteome Res. 2009 Feb; 8(2):620-30.
    View in: PubMed
    Score: 0.003
  55. Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity? DNA Cell Biol. 2006 Mar; 25(3):165-70.
    View in: PubMed
    Score: 0.003
  56. alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses. Antimicrob Agents Chemother. 2004 Jun; 48(6):2085-90.
    View in: PubMed
    Score: 0.002
  57. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003 Aug 11; 22(33):5093-107.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.